Clinical significance of the antibody against oxidized low-density lipoprotein in acute myocardial infarction

Cardiology

Volumn 98, Issue 1-2, 2002, Pages 13-17

  Inoue, Teruo ^a   Yaguchi, Isao ^a   Uchida, Toshihiko ^a   Kamishirado, Hirotoshi ^a   Nakahara, Shiro ^a   Hayashi, Terumi ^a   Morooka, Shigenori ^a  

^a DOKKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Acute myocardial infarction; Antibody; Oxidized low density lipoprotein; Plaque instability

Indexed keywords

FIBRINOLYTIC AGENT; MONTEPLASE; OXIDIZED LOW DENSITY LIPOPROTEIN; PROTEIN ANTIBODY;

ADULT; ANGIOCARDIOGRAPHY; ANTIBODY TITER; ARTICLE; BLOOD CLOT LYSIS; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DILATATION; FEMALE; FIBRINOLYTIC THERAPY; HEART INFARCTION; HOSPITAL ADMISSION; HUMAN; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECANALIZATION; RISK ASSESSMENT; RISK FACTOR;

ANTIBODIES; ARTERIES; BIOLOGICAL MARKERS; CHOLESTEROL, LDL; CORONARY ANGIOGRAPHY; CORONARY VESSELS; FEMALE; HUMANS; JAPAN; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PATIENT ADMISSION; PROSPECTIVE STUDIES; TREATMENT OUTCOME; VASCULAR PATENCY;

EID: 0036434070     PISSN: 00086312     EISSN: None     Source Type: Journal    
DOI: 10.1159/000064672     Document Type: Article

References (15)

1. Witztum JL, Steinberg D: Role of oxidized low density lipoprotein in atherogenesis. J Clin Invest 1991;88:1785-1792.
2. Palinski W, Ylä-Herttuala S, Rosenfeld ME, et al: Antisera and monoclonal antibodies specific for epitopes generated during oxidative modification of low density lipoprotein. Arteriosclerosis 1990;10:325-335.
3. Parumus DV, Brown DL, Mitchison MJ: Serum antibodies to oxidized low density lipoprotein and ceroid in chronic periaortitis. Arch Pathol Lab Med 1990;114:383-387.
4. Tatzber F, Rabi H, Koriska K, et al: Elevated serum neoprotein levels in atherosclerosis. Atherosclerosis 1991;89:203-208.
5. Maggi E, Finardi G, Poli M, et al: Specificity of autoantibodies against oxidized LDL as an additional marker for atherosclerotic risk. Coron Artery Dis 1993;4:1119-1122.
6. Lehtimaki T, Lehtinen S, Solakivi T, et al: Autoantibodies against oxidized low density lipoprotein in patients with angiographically verified coronary artery disease. Arterioscler Tromb Vasc Biol 1999;19:23-27.
7. Salonen JT, Ylä-Herttuala S, Yamamoto R, et al: Autoantibody against oxidized LDL and progression of carotid atherosclerosis. Lancet 1992;339:883-887.
8. Bergmark C, Wu R, de Faire U, Lefvert AK, Swedenborg J: Patients with early-onset peripheral vascular disease have increased levels of autoantibodies against oxidized LDL. Arterioscler Thromb Vasc Biol 1995;15:441-445.
9. Inoue T, Uchida T, Kamishirado H, Takayanagi K, Hayashi T, Morooka S: Clinical significance of antibody against oxidized low density lipoprotein in patients with atherosclerotic coronary artery disease. J Am Coll Cardiol 2001;37:775-779.
10. Puurunen M, Mânttâri M, Manninen V, et al: Antibody against oxidized low-density lipoprotein predicting myocardial infarction. Arch Intern Med 1994;154:2605-2609.
11. Ryan M, Owens D, Kilbridge B, Collins P, Johnson A, Tomkin GH: Antibodies to oxidized lipoproteins and their relationship to myocardial infarction. Q J Med 1998;91:411-415.
12. Fogelman AM, Schechter I, Seager J, Hokom M, Child JS, Edwards PA: Malondialdehyde alteration of low density lipoproteins leads to cholesterol ester accumulation in human monocyte-macrophages. Proc Natl Acad Sci USA 1980;77:2214-2218.
13. Morel DW, DiCorieto PE, Chisholm GM: Endothelial and smooth muscle cells alter low density lipoprotein in vitro by free radical oxidation. Arteriosclerosis 1984;4:356-364.
14. Quinn MT, Parthasarathy S, Fong LG, Steinberg D: Oxidatively modified low density lipoproteins: A potential role in recruitment and retention of monocyte/macrophages during atherosclerosis. Proc Natl Acad Sci USA 1987;84:2995-2998.
15. Quinn MT, Parthasarathy S, Steinberg D: Endothelial cell-derived chemotactic activity for mouse peritoneal macrophages and the effects of low density lipoprotein. Proc Natl Acad Sci USA 1985;85:5949-5953.